Publication | Closed Access
Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: contribution from <i><scp>ATP</scp>8B1/<scp>ABCB</scp>11</i> mutations?
59
Citations
12
References
2013
Year
AAS marketed as dietary supplements continue to cause hepatotoxicity in the UK; underlying mechanisms may include unmasking of genetic cholestatic syndromes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1